首页> 美国卫生研究院文献>Thorax >Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.
【2h】

Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.

机译:钴57-博来霉素扫描支气管癌患者肺门和纵隔的前瞻性研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Because the results with cobalt-57-bleomycin (57Co-bleo) as a tumour-seeking agent in patients with pulmonary tumours were promising, a prospective study was carried out to test the sensitivity and selectivity of this technique for metastases in lung hila and mediastinum in a group of patients with bronchial cancer. The sensitivity of 57Co-bleo scintigraphy appeared to be higher than that of routine radiological investigations and mediastinoscopy. For this reason it is suggested that 57Co-bleo scintigraphy can be used as a method to select patients for mediastinoscopy.
机译:由于以57钴钴霉素(57Co-bleo)作为肺肿瘤患者的肿瘤寻找药物的结果是有希望的,因此进行了一项前瞻性研究,以测试该技术对肺门和纵隔转移的敏感性和选择性在一组患有支气管癌的患者中。 57Co闪烁闪烁显像的敏感性似乎高于常规放射学检查和纵隔镜检查。因此,建议将57Co-bleo闪烁显像术用作选择纵隔镜检查患者的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号